drugset / Trial / NCT07033533
Allopurinol and Pathogenesis of Cirrhosis
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Hepatic decompensation is a common healthcare issue . This study was conducted to investigate how allopurinol can interfere with the pathological mechanisms of HD.
Timeline
- Start
- 2023-06-01
- Primary completion
- 2024-03-01
- Completion
- 2024-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Allopurinol | Small molecule | — | — |